<qa>  What is the hypothesis 2 of the treatment with Liraglutide?Hypothesis 2: Treatment with Liraglutide in patients with type 1 diabetes decreases basal and postprandial glucagon concentrations and increases basal and postprandial C-peptide concentrations. 